Raj Chovatiya, MD, PhD: Safety of Oral JAK Inhibitors for Atopic Dermatitis

Dr. Rosen discusses notable papers that he reviewed in his Maui Derm NP+PA Fall Literature Review presentation.

In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Shapiro covers the spectrum of hair disorders from non-scarring to scarring alopecias and

Melodie Young provides a recap of her contribution to the Psoriasis and Psoriatic Arthritis 2023 session presented at Maui Derm NP+PA Fall.

Victoria Lazareth discusses how NPs and PAs can gain confidence with treating their patients with new systemic drugs for atopic dermatitis.

In a recap of her Maui Derm NP+PA Fall 2023 session, Dr. Baldwin discussed advances in topical and oral treatments for patients with acne.

o In a recap of his Maui Derm NP+PA Fall 2023 session, Doug DiRuggiero shares insights on diagnosing nonspecific rashes and managing dermatitis in connection

Dr. Zirwas provides an enthusiastic overview of how our arsenal of atopic dermatitis treatments work to improve atopic dermatitis.

Shanna Miranti discusses how NPs and PAs can improve their patient care by taking advantage of the new options available to clinicians.

Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in

In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Chovatiya discusses the array of new drug approvals for AD, including biologics, oral

Victoria Lazareth discussed topics covered during the Surgical Procedural Workshop, which took place during the meeting’s Pre-Conference Day.

Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.

Dr. Chovatiya discusses safety data on upadacitinib and abrocitinib for the treatment of atopic dermatitis.

In a recap of his Maui Derm NP+PA Fall 2023 session, Dr. Zirwas discusses some of the most exciting new papers published this year in